Send me a link:

*Text messaging rates may apply.

 Dow Down 1.51% Nasdaq Down 1.80%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.31 Down 0.01(0.76%) 3:07PM EDT - Nasdaq Real Time Price
Prev Close:1.32
Open:1.30
Bid:1.29 x 9200
Ask:1.30 x 1800
1y Target Est:2.81
Beta:0.92
Next Earnings Date: 6-Aug-14NAVB Earnings announcement
Day's Range:1.29 - 1.31
52wk Range:1.11 - 3.15
Volume:261,079
Avg Vol (3m):981,989
Market Cap:195.49M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 0.76%195.49M
LLYDown 2.31%65.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):104.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback